02 Aug 2019
Indian pharma companies find new growth opportunities in China
By Staff Writer
Indian pharmaceutical companies are finding lucrative opportunities for growth in the Chinese pharma market, which is set to rise from nearly US$132bn in 2018 to more than US$209bn by 2022, says GlobalData, a leading data and analytics company. Prashant Khadayate, pharma analyst at GlobalData, comments: ‘The Chinese pharma market is the second largest pharma market...